TITLE

Esophageal Abscess Complicating Endoscopic Treatment of Refractory Gastroesophageal Reflux Disease by Enteryx Injection: A First Case Report

AUTHOR(S)
Tintillier, Michel; Chaput, André; Kirch, Lotti; Martinet, Jean-Paul; Pochet, Jean-Michel; Cuvelier, Charles
PUB. DATE
September 2004
SOURCE
American Journal of Gastroenterology;Sep2004, Vol. 99 Issue 9, p1856
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Enteryx (Boston Scientific) is an injectable solution containing 8% ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide that has been approved for the treatment of gastroesophageal reflux disease (GERD). The technique consists of injecting Enteryx into the lower esophageal sphincter where it solidifies into a sponge-like permanent implant and prevents or reduces gastric acid reflux into the esophagus. The procedure appears to be generally safe, even if minor or moderate adverse events have been observed.We present the case of a 52-yr-old female treated by Enteryx injection for GERD who developed subsequently an esophageal parietal abscess.(Am J Gastroenterol 2004;99:1856-1858)
ACCESSION #
14816428

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics